GWA
RXST icon

GGM Wealth Advisors’s RxSight RXST Stock Holding History

GGM Wealth Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$242K Buy
16,618
+9,360
+129% +$278K 0.13% 116
2024
Q4 		$250K Hold
7,258
– – 0.13% 120
2024
Q3 		$359K Hold
7,258
– – 0.15% 101
2024
Q2 		$437K Buy
+7,258
New +$415K 0.2% 81

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

GGM Wealth Advisors's RXST Position: Q1 2025 in Review

GGM Wealth Advisors increased its RxSight (RXST) stake by 129% in Q1 2025, buying an estimated $278K and bringing the position to 16,618 shares worth $242K. The position accounts for 0.13% of the portfolio, ranked #116.

GGM Wealth Advisors first reported a position in RXST in Q2 2024 and has held it in 4 quarters since. The position peaked at $437K in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • GGM Wealth Advisors held 16,618 shares of RxSight worth $242K as of Q1 2025.
  • GGM Wealth Advisors bought 9,360 RxSight shares in Q1 2025, an estimated $278K.
  • RxSight made up 0.13% of GGM Wealth Advisors's portfolio in Q1 2025, its #116 holding.
  • GGM Wealth Advisors first reported a position in RxSight in Q2 2024 and has held it in 4 quarters since.
  • GGM Wealth Advisors's RxSight position peaked at $437K in Q2 2024.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on GGM Wealth Advisors's 13F filing for Q1 2025, filed 1 May 2025.